← Eichor
Condition: Dry Age Related Macular Degeneration Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Dry Age Related Macular Degeneration

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Post-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With End-stage Age-related Mac
NA · 13 location(s) · VisionCare, Inc. · NCT04796545(CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 and the CIRRUS 5000
NA · 6 location(s) · Carl Zeiss Meditec-Dublin CoCe · NCT07680244A Phase 1/2 Study to Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic
Phase 1/Phase 2 · 1 location(s) · Bionic Sight LLC · NCT07158775Atrophic Age-related Macular Degeneration Treated With Intravitreal Injections of Umbilical Cord Blood Platelet-rich Pla
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05706896A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)
Phase 2 · 5 location(s) · Regenerative Patch Technologies, LLC · NCT06557460Age-related Macular Degeneration of Atrophic Type Treated With Umbilical Cord Blood Enriched With Platelet Plasma.
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06536062Subthreshold Laser Treatment for Reticular Pseudodrusen Secondary to Age-related Macular Degeneration
NA · 3 location(s) · Ospedale San Raffaele · NCT04847635Effects of Antiplatelet and Antioxidant Agents on Drusen Progression: A Pilot, Prospective Cohort Study
Phase 3 · 1 location(s) · Navamindradhiraj University · NCT06165068Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation in Patients With Dry Age-related Macular
Phase 1/Phase 2 · 3 location(s) · Luxa Biotechnology, LLC · NCT04627428Real-World Evaluation of AI Enabled Multi-Spectral Imaging (MSI) for AMD Biomarker Detection
Phase N/A · 1 location(s) · AI-Spectral · NCT07446582Effect of Omega-3 Fatty Acid Supplementation on Dry-AMD Progression
NA · 1 location(s) · Shanghai General Hospital, Shanghai Jiao Tong University Sch · NCT05465252Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration.
Phase 1/Phase 2 · 3 location(s) · Eyestem Research Pvt. Ltd. · NCT06394232Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy As
Phase 1/Phase 2 · 2 location(s) · National Eye Institute (NEI) · NCT04339764A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due
Phase 1 · 19 location(s) · Astellas Institute for Regenerative Medicine · NCT03178149Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study
NA · 1 location(s) · Medical University of Vienna · NCT03921931Survival of Monocytes Collected From Patients With Atrophic AMD in Retinal Pigmented Epithelium Explants
NA · 2 location(s) · Hospices Civils de Lyon · NCT04697095High Resolution, High-speed Multimodal Ophthalmic Imaging
NA · 1 location(s) · Centre Hospitalier National d'Ophtalmologie des Quinze-Vingt · NCT04129021A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
Phase N/A · 13 location(s) · Complement Therapeutics · NCT07144137A Registry Study to Assess Photobiomodulation in Dry Age-Related Macular Degeneration (EUROLIGHT) (EUROLIGHT)
Phase N/A · 1 location(s) · LumiThera, Inc. · NCT06351605AVIGA3 (Cohort 2.0)
NA · 1 location(s) · Tan Tock Seng Hospital · NCT07255859Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
NA · 15 location(s) · i-Lumen Scientific AUS PTY LTD · NCT06662162Photobiomodulation in Dry Age Related Macular Degeneration
NA · 7 location(s) · Azienda Ospedaliera Universitaria Mater Domini, Catanzaro · NCT06046118Stem Cell Ophthalmology Treatment Study II
NA · 4 location(s) · MD Stem Cells · NCT03011541
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.